Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
AFLIBERCEPT
Zaltrap
Cancer
EFC10547VANILLANCT00574275Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
EFC10668AFFIRMNCT00851084Tabulated Results
AFLIBERCEPT
Zaltrap
Colorectal cancer
EFC11338AFLAMENCT01661270Tabulated Results
AFLIBERCEPT
Zaltrap
Colorectal cancer
EFC11885NANCT01882868Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
EFC6125NANCT00327444Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
EFC6546NANCT00519285Tabulated Results
AFLIBERCEPT
Zaltrap
Non Hodgkins Lymphoma
TCD10173NANCT00644124Summary
AFLIBERCEPT
Zaltrap
Cancer
TCD11382NANCT01148615Summary
AFLIBERCEPT
Zaltrap
Cancer
TCD11470NANCT01930552Summary
AFLIBERCEPT
Zaltrap
Cancer
TCD6117NASummary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted